The diabetes pandemic: Looking for the silver lining

Clinical Diabetes

Volumn 23, Issue 2, 2005, Pages 51-52

  Venkat Narayan, K M ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DIABETES CONTROL; DIABETES MELLITUS; EDITORIAL; EPIDEMIC; HUMAN; MEDICAL RESEARCH; PREVALENCE;

EID: 22044453941     PISSN: 08918929     EISSN: 08918929     Source Type: Journal    
DOI: 10.2337/diaclin.23.2.51     Document Type: Editorial

References (7)

1. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884-1890, 2003
2. International Diabetes Federation: Diabetes Atlas, 2nd ed. Brussels, Belgium, International Diabetes Federation, 2003
3. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
4. The UKPDS Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
5. The UKPDS Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703-713, 1998
6. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM,Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
7. Narayan KM, Benjamin E, Gregg EW, Norris SL, Engelgau MM: Diabetes translation research: where are we and where do we want to be? Ann Intern Med 140:958-963, 2004